Gulf & Middle East · General news · Gulf Daily News

Johnson & Johnson's prostate cancer drug shrinks tumours in early-stage trial

Published by Gulf Daily News · Bahrain 18 h ago

Johnson & Johnson on Saturday said its experimental once-daily oral prostate cancer drug caused tumours to disappear or shrink in an early-stage ‌trial. J&J had gained access to…

Read the full article on Gulf Daily News Sign in to save

MarketNews shows the headline and summary published by the outlet. The full article is on the publisher's website. (www.gdnonline.com)

Also worth reading

The National

Saudi-led coalition says it destroyed Houthi ballistic missiles fired towards Yanbu and Taif

Al-Monitor

To bring down Netanyahu, Arab-Israeli parties ready for opposition alliance

The Times of Israel

Johnson & Johnson's prostate cancer drug shrinks tumours in early-stage trial

Share

Also worth reading

Vincent Kompany 'stable' in hospital after collapsing at Bayern Munich training

Ethiopian PM’s advisor: Tigrayan forces and others hinder stability

‘Da Hawaiian’ retains super heavyweight title at Power Slap 25 in Abu Dhabi

Saudi-led coalition says it destroyed Houthi ballistic missiles fired towards Yanbu and Taif

To bring down Netanyahu, Arab-Israeli parties ready for opposition alliance

France mobilizes 70,000 cops ahead of nationwide protests as Paris museums, businesses close for the day